Making it Work Program for Systemic Sclerosis
NCT06338722 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2025-02-13
Summary
The purpose of this clinical trial is to see if an online intervention program for people with Systemic Sclerosis (scleroderma) helps keep people in the workforce and increase self-confidence in dealing with challenges at work. The program is called Making it Work Systemic Sclerosis.
Researchers will compare a group who gets the program to a group who will get the program at a later point in time (wait list control group) to see if self-confidence in dealing with work challenge gets better.
People in the Making it Work group will complete questionnaires and attend one 2 hour meetings each week for 5 weeks and meet with an occupational therapist and vocational counselor. People in the wait list control group will complete the questionnaires and participate in the program at a later point in time.
Conditions
- Scleroderma, Systemic
Interventions
- OTHER
-
Making it Work Systemic Sclerosis
One 2 hour virtual meeting per week for 5 weeks, plus an individual meeting with an occupational therapist and a vocational counselor
Sponsors & Collaborators
-
University of New Mexico
lead OTHER
Principal Investigators
-
Janet L Poole · University of New Mexico
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 67 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-08
- Primary Completion
- 2025-01-22
- Completion
- 2025-01-22
Countries
- United States
Study Locations
More Related Trials
-
Taking Charge of Systemic Sclerosis
NCT02494401 ·Status: COMPLETED ·Phase: NA
-
Self-management Telehealth Program for Scleroderma
NCT06990386 ·Status: COMPLETED ·Phase: NA
-
SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF)
NCT04246528 ·Status: COMPLETED ·Phase: NA
-
Delving Into Participation Trends of Scleroderma Clinical Trials
NCT06264492 ·Status: NOT_YET_RECRUITING
-
Exercise in People With Systemic Sclerosis
NCT05234671 ·Status: COMPLETED ·Phase: NA
-
The Scleroderma Patient-centered Intervention Network (SPIN) Support Group Leader Education Program Feasibility Trial
NCT03508661 ·Status: COMPLETED ·Phase: NA
-
SPIN Self-Management Feasibility Trial
NCT03914781 ·Status: COMPLETED ·Phase: NA
-
The SPIN - Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED)
NCT03965780 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
NCT06297096 ·Status: RECRUITING ·Phase: PHASE3
-
Pragmatic Clinical Trials in Scleroderma
NCT03610217 ·Status: UNKNOWN ·Phase: NA
-
Patients Diagnosed With Scleroderma: Physical Performance and Functionality
NCT07183072 ·Status: RECRUITING
-
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT05177380 ·Status: UNKNOWN ·Phase: NA
-
Gut Microbiota Transplantation in Systemic Sclerosis
NCT03444220 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis
NCT06546540 ·Status: RECRUITING ·Phase: PHASE4
-
Scleroderma Patient-centered Intervention Network (SPIN) Hand Program
NCT03419208 ·Status: COMPLETED ·Phase: NA
-
Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis
NCT00318188 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis
NCT03271320 ·Status: COMPLETED
-
Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis
NCT02558543 ·Status: TERMINATED ·Phase: PHASE2
-
Platform Clinical Study for Conquering Scleroderma
NCT06195072 ·Status: RECRUITING ·Phase: PHASE2
-
Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study
NCT03092024 ·Status: COMPLETED ·Phase: NA
-
Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis
NCT01895244 ·Status: COMPLETED ·Phase: PHASE2
-
Longitudinal Spatial Frequency Domain Imaging Study
NCT05672992 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Benefit of Bermekimab in Patients With Systemic Sclerosis
NCT04045743 ·Status: COMPLETED ·Phase: PHASE2
-
Fresolimumab In Systemic Sclerosis
NCT01284322 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Adipose Tissue in the Treatment of Systemic Sclerosis Digital Ulcers
NCT03406988 ·Status: UNKNOWN ·Phase: NA